King Pharmaceuticals®, Inc. Announces Final Results of Its Offer to Purchase Convertible Notes
3/1/2011 1:52:35 PM
BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (the “Company”), a wholly owned subsidiary of Pfizer Inc., announced today the final results of its tender offer to purchase (the “Fundamental Change Put Option”) any and all of its outstanding 1 1/4% Convertible Senior Notes Due 2026 (the “Securities”). The Fundamental Change Put Option expired on February 28, 2011, at 11:59 p.m., New York City time (the “Expiration Date”).
comments powered by